FSMAX
Price
$121.15
Change
+$0.23 (+0.19%)
Updated
Aug 14 closing price
Net Assets
40.08B
IRMCX
Price
$9.23
Change
+$0.07 (+0.76%)
Updated
Aug 13 closing price
Net Assets
807.95M
Interact to see
Advertisement

FSMAX vs IRMCX

FSMAX vs IRMCX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. IRMCX commentary
Aug 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Buy and IRMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40.1B vs. IRMCX (808M). IRMCX pays higher dividends than FSMAX: IRMCX (0.75) vs FSMAX (0.50). FSMAX was incepted earlier than IRMCX: FSMAX (15 years) vs IRMCX (18 years). IRMCX (0.84) is less costly to investors than FSMAX (0.04). IRMCX is a more actively managed with annual turnover of: 26.00 vs. FSMAX (23.00). FSMAX (0) and IRMCX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 25.93 vs. IRMCX (-11.16). FSMAX return over 5 years is better than : 40.97 vs. IRMCX (-29.55).
FSMAXIRMCXFSMAX / IRMCX
Total Expense Ratio0.040.655%
Annual Report Gross Expense Ratio0.040.844%
Fund Existence15 years18 years-
Gain YTD20.344-13.311-153%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets40.1B808M4,963%
Annual Yield % from dividends0.500.7567%
Returns for 1 year25.93-11.16-232%
Returns for 3 years74.27-6.02-1,234%
Returns for 5 years40.97-29.55-139%
Returns for 10 years144.05-28.54-505%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NRGSX63.080.17
+0.27%
Neuberger Genesis R6
GCVAX29.84N/A
N/A
Goldman Sachs Large Cp Val Insghts A
QOPYX25.77N/A
N/A
Invesco Multi-Strategy Fund Y
TRPBX27.30N/A
N/A
T. Rowe Price Spectrum Moderate Allc Inv
MPEMX11.15N/A
N/A
Mondrian Emerging Markets Value Equity